Apr 1
Filing
SEDAR+
52-109F1 - Certification of annual filings - CFO (E)
FRX · Fennec Pharmaceuticals Inc. · Documents
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →
2024
Apr 1
Filing
SEDAR+
Participation Fee Form
Apr 1
Report
SEDAR+
Annual information form
Apr 1
Report
SEDAR+
Audited annual financial statements
Apr 1
Filing
SEDAR+
Participation Fee Form
Apr 1
Announcement
SEDAR+
News release
Mar 29
Annual report
10-K
FY2023, ended Dec 31
Annual report for FY2023
Revenue $21.25M
▲ 1284.5%
Net loss $16.05M
Diluted EPS -$0.60
Mar 25
Current report
8-K
Events of Mar 21
Financial results
Mar 21
Earnings call
Q4 2023 earnings call
Mar 21
Current report
8-K
Events of Mar 15
Entered into a material agreement, Other events
Mar 21
Announcement
SEDAR+
News release
Mar 21
Announcement
SEDAR+
News release
Mar 21
Announcement
SEDAR+
Material change report
Mar 17
Announcement
SEDAR+
News release
Mar 6
Current report
8-K/A
Events of Feb 29
Financial results
Feb 29
Current report
8-K
Other events
Feb 2
Current report
8-K
Events of Feb 1
Other events
2023
Dec 15
Filing
SEDAR+
Offering material
Dec 7
Announcement
SEDAR+
Material change report
Dec 7
Dec 6
Current report
8-K
Events of Dec 4
Entered into a material agreement, New debt or off-balance-sheet obligation, Unregistered sale of equity, Other events
Dec 5
Announcement
SEDAR+
News release
Nov 10
Announcement
SEDAR+
News release
Nov 10
Report
SEDAR+
Interim financial statements/report
Nov 10
Report
SEDAR+
MD&A
Nov 10
Filing
SEDAR+
52-109F2 - Certification of interim filings - CEO (E)
Nov 10
Filing
SEDAR+
52-109F2 - Certification of interim filings - CFO (E)
Nov 9
Quarterly report
10-Q
FY2023 Q3, ended Sep 30
Quarterly report for FY2023 Q3
Revenue $6.52M
Net loss $1.87M
Diluted EPS -$0.07
Nov 9
Registration statement
S-3
Registration statement
Nov 7
Current report
8-K
Events of Nov 6
Financial results
Nov 6
Earnings call
Q3 2023 earnings call
Nov 6
Announcement
SEDAR+
News release
Aug 8
Report
SEDAR+
MD&A
Aug 8
Filing
SEDAR+
52-109F2 - Certification of interim filings - CEO (E)
Aug 8
Filing
SEDAR+
52-109F2 - Certification of interim filings - CFO (E)
Aug 8
Announcement
SEDAR+
News release
Aug 8
Report
SEDAR+
Interim financial statements/report
Aug 7
Current report
8-K/A
Events of Aug 3
Director or officer change, or executive pay
Aug 7
Quarterly report
10-Q
FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Net loss $5.44M
Diluted EPS -$0.21
Aug 4
Current report
8-K
Events of Aug 3
Financial results
Aug 4
Current report
8-K
Events of Aug 3
Director or officer change, or executive pay
Aug 3
Earnings call
Q2 2023 earnings call
Jun 13
Current report
8-K
Events of Jun 12
Shareholder vote results
Jun 13
Filing
SEDAR+
Report of voting results
Jun 7
Current report
8-K
Events of Jun 6
Other events
Jun 1
Filing
SEDAR+
52-109F2 - Certification of interim filings - CEO (E)
Jun 1
Announcement
SEDAR+
News release
Jun 1
Report
SEDAR+
MD&A
Jun 1
Filing
SEDAR+
Continuous Disclosure
Jun 1
Filing
SEDAR+
52-109F2 - Certification of interim filings - CFO (E)
Showing 151–200 of 527 documents